Anxiety & Stress Disorders

From historic USPSTF draft screening recommendations to the need for novel treatments for bipolar depression, here are highlights from the week in Psychiatric Times.

How can we increase assessment of anxiety without increasing other problems? Where is the balance?

For the first time, the USPSTF is recommending anxiety screening for adults under 65.

The first patient has been dosed in the phase 2b dose-optimization trial of a pharmaceutically optimized form of LSD for the treatment of generalized anxiety disorder.

With more immigrant students enrolling in US colleges, what can we do to help with their transition?

Treatments alter the neural processes underlying SAD symptoms.

The most common issues during the COVID-19 pandemic included stress, anxiety.

The experts weighed in on a wide variety of psychiatric issues for the Psychiatric Times February 2022 issue.

Here’s how to help patients—and ourselves—recognize cognitive distortions.

Treatment decisions lie on a continuum—befitting a dimensional approach to diagnosis.

Exploring cognitive biases toward the DSM and their avoidable effects on treatment decisions.

Research also shows increased prevalence of social risks and unmet social needs.

Individuals with ADHD are 4 times more likely to have generalized anxiety disorder at some point in their life.

Are your patients feeling stressed out? Here are 10 tips to share with them for a less stressful holiday season.

Why are psychotherapeutic interventions crucial in the treatment of GAD and anxiety disorders in general?

Loss and suffering can be hard for both patient and provider. Here’s what we know, what we need to learn, and how to protect yourself as a clinician.

PH94B for the treatment of social anxiety disorder further differentiates its mechanism of action from benzodiazepines in a new lab rat preclinical study.

A study compared matcha, a highly caffeinated green tea, to other sources of caffeine. Which had the greatest cognitive benefits?

A patient presents with multiple substance use disorders super-imposed on mood and anxiety disorders. Where does a clinician even begin?

Key questions to consider when evaluating a digital therapeutic for anxiety.

What will psychiatric practice look like in the year 2030?

What are the greatest unmet mental health needs in the United States today? Recent statistics from the Centers for Disease Control may hold the answers.

A working model for eliminating stigma and transforming mental healthcare within the military.

Why does the prospect of getting back to normal after the pandemic disturb some patients? And what can be done to overcome these fears?

Resilience is a relatively neglected topic of research, but it has the power to dramatically improve patients' lives.

How should the sociopolitical nature of PTSD as a diagnosis inform our understanding of trauma?

Research confirms COVID-19’s negative impact on Americans’ mental health.

New research find altered states of consciousness may allow veterans and other patients with PTSD to face unspeakable experiences and find peace.

In this conversation, a former APA president discusses mystical and meditative experiences, reconciling psychoanalysis and neuroscience, and tensions surrounding the medical model.

A television drama looks at eating disorders from the patient, physician, and family perspectives. What does it get right—and wrong?